BDNF in schizophrenia, depression and corresponding animal models

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Molecular Psychiatry

• Publication date

  2005-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/sj.mp.4001637PMID 15655562
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Down-regulation of the Trk-B signal pathway: the possible pathogenesis of major depression.

  2004cited by this paper
• Cell loss in the hippocampus of schizophrenics

  2004cited by this paper
• Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway.

  2004cited by this paper
• Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions.

  2004cited by this paper
• Electroconvulsive Seizures Regulate Gene Expression of Distinct Neurotrophic Signaling Pathways

  2004cited by this paper
• Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains.

  2003cited by this paper
• The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia.

  2003cited by this paper
• Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats

  2003cited by this paper
• Neurotrophin secretion: current facts and future prospects.

  2003cited by this paper
• Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression.

  2003cited by this paper
• Forebrain-specific trkB-receptor knockout mice: behaviorally more hyperactive than "depressive".

  2003cited by this paper
• Effect of antipsychotic drugs on brain‐derived neurotrophic factor expression under reduced N‐methyl‐D‐aspartate receptor activity

  2003cited by this paper
• Neonatal lesions in the amygdala or ventral hippocampus disrupt prepulse inhibition of the acoustic startle response; implications for an animal model of neurodevelopmental disorders like schizophrenia.

  2003cited by this paper
• Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression.

  2003cited by this paper
• The Fawn-Hooded (FH/Wjd) rat: a genetic animal model of comorbid depression and alcoholism

  2002cited by this paper
• What role do atypical antipsychotic drugs have in treatment-resistant depression?

  2002cited by this paper
• Neonatal Damage of the Ventral Hippocampus Impairs Working Memory in the Rat

  2002cited by this paper
• Evidence that brain‐derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice

  2002cited by this paper
• Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus.

  2002cited by this paper
• Long-lasting effects of prenatal MAM treatment on water maze performance in rats: associations with altered brain development and neurotrophin levels.

  2002cited by this paper
• Neurobiology of depression.

  2002cited by this paper
• Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression

  2002cited by this paper
• Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus

  2002cited by this paper
• Electroconvulsive Stimuli Alter the Regional Concentrations of Nerve Growth Factor, Brain-Derived Neurotrophic Factor, and Glial Cell Line-Derived Neurotrophic Factor in Adult Rat Brain

  2002cited by this paper
• Novel polymorphisms in the promoter region of the neurotrophin-3 gene and their associations with schizophrenia.

  2002cited by this paper
• Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor.

  2002cited by this paper
• Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients.

  2002cited by this paper
• The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.

  2002cited by this paper
• Brain-derived neurotrophic factor (BDNF) mRNA in rats with neonatal ibotenic acid lesions of the ventral hippocampus.

  2002cited by this paper
• Amygdala or ventral hippocampal lesions at two early stages of life differentially affect open field behaviour later in life; an animal model of neurodevelopmental psychopathological disorders.

  2002cited by this paper
• Decreased serum brain-derived neurotrophic factor levels in major depressed patients.

  2002cited by this paper
• Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents.

  2001cited by this paper
• Research and treatment approaches to depression

  2001cited by this paper
• Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers.

  2001cited by this paper
• Atypical antipsychotics in bipolar and schizoaffective disorders.

  2001cited by this paper
• BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs

  2001cited by this paper
• Bromodeoxyuridine and methylazoxymethanol exposure during brain development affects behavior in rats: consideration for a role of nerve growth factor and brain derived neurotrophic factor.

  2001cited by this paper
• The influence of gender and the estrous cycle on learned helplessness in the rat.

  2001cited by this paper
• Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain

  2001cited by this paper
• Brain-derived-neurotrophic-factor (BDNF) stress response in rats bred for learned helplessness

  2001cited by this paper
• Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses.

  2001cited by this paper
• Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers

  2001cited by this paper
• Depresssion--emerging insights from neurobiology.

  2001cited by this paper
• BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization

  2001cited by this paper
• Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.

  2001cited by this paper
• Altered hormone levels and circadian rhythm of activity in the WKY rat, a putative animal model of depression.

  2001cited by this paper
• Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia‐like disorders

  2000cited by this paper
• Data and hypotheses on the role of nerve growth factor and other neurotrophins in psychiatric disorders.

  2000cited by this paper
• Cytokine and growth factor involvement in schizophrenia—support for the developmental model

  2000cited by this paper
• Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions.

  2000cited by this paper
• Hippocampal volume reduction in major depression.

  2000cited by this paper
• Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients

  2000cited by this paper
• Brain‐derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration

  2000cited by this paper
• Prenatal exposure to methylazoxymethanol acetate in the rat alters neurotrophin levels and behavior: considerations for neurodevelopmental diseases.

  2000cited by this paper
• Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells.

  2000cited by this paper
• Mapping the differences in the brain concentration of brain‐derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression

  2000cited by this paper
• Cell biology of the hippocampal formation in schizophrenia.

  1999cited by this paper
• The neuropathology of schizophrenia. A critical review of the data and their interpretation.

  1999cited by this paper
• Depression Duration But Not Age Predicts Hippocampal Volume Loss in Medically Healthy Women with Recurrent Major Depression

  1999cited by this paper
• Neurotrophins and depression.

  1999cited by this paper
• Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain.

  1999cited by this paper
• Low nerve growth factor plasma levels in schizophrenic patients: a preliminary study.

  1999cited by this paper
• Interruptions of early cortical development affect limbic association areas and social behaviour in rats; possible relevance for neurodevelopmental disorders.

  1999cited by this paper
• Cytokines and neurotrophins in psychiatric disorders

  1999cited by this paper
• Prenatal methylazoxymethanol acetate alters behavior and brain NGF levels in young rats: a possible correlation with the development of schizophrenia-like deficits.

  1999cited by this paper
• Neurotrophin trafficking by anterograde transport.

  1998cited by this paper
• Methylazoxymethanol acetate-induced abnormalities in the entorhinal cortex of the rat; parallels with morphological findings in schizophrenia.

  1998cited by this paper
• Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses

  1998cited by this paper
• A molecular and cellular theory of depression.

  1997cited by this paper
• 5-HT2A Receptor-Mediated Regulation of Brain-Derived Neurotrophic Factor mRNA in the Hippocampus and the Neocortex

  1997cited by this paper
• Electrolytic lesions of the medial prefrontal cortex in rats disrupt performance on an analog of the Wisconsin Card Sorting Test, but do not disrupt latent inhibition: implications for animal models of schizophrenia.

  1997cited by this paper
• Ligand-induced down-regulation of Trk messenger RNA, protein and tyrosine phosphorylation in rat cortical neurons.

  1997cited by this paper
• Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain.

  1997cited by this paper
• Developmental models of brain dysfunctions induced by targeted cellular ablations with methylazoxymethanol.

  1997cited by this paper
• Cytoarchitecture of the entorhinal cortex in schizophrenia.

  1997cited by this paper
• Schizophrenia and neurotrophin‐3 alleles

  1997cited by this paper
• Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood

  1997cited by this paper
• Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).

  1997cited by this paper
• Why Stress Is Bad for Your Brain

  1996cited by this paper
• Autocrine—paracrine Regulation of Hippocampal Neuron Survival by IGF‐1 and the Neurotrophins BDNF, NT‐3 and NT‐4

  1996cited by this paper
• Phencyclidine‐induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia

  1996cited by this paper
• The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression.

  1996cited by this paper
• Neonatal Insult to the Hippocampal Region and Schizophrenia: A Review and a Putative Animal Model

  1996cited by this paper
• Autocrine BDNF secretion enhances the survival and serotonergic differentiation of raphe neuronal precursor cells grafted into the adult rat CNS.

  1996cited by this paper
• Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments

  1995cited by this paper
• BDNF attenuates the effects of intrastriatal injection of 6‐hydroxydopamine

  1995cited by this paper
• The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats.

  1995cited by this paper
• Chronic mild stress‐induced anhedonia model of depression: sleep abnormalities and curative effects of electroshock treatment

  1995cited by this paper
• Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock.

  1995cited by this paper
• Prenatal development of monozygotic twins and concordance for schizophrenia.

  1995cited by this paper
• Effects of Stress on Neurotrophic Factor Expression in the Rat Brain

  1995cited by this paper
• Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain

  1995cited by this paper
• Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground.

  1995cited by this paper
• Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus

  1995cited by this paper
• Expression of neurotrophin and trk receptor genes in adult rats with fimbria transections: effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration.

  1994cited by this paper
• Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon

  1994cited by this paper
• Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3.

  1994cited by this paper
• Requirement for BDNF in activity-dependent survival of cortical neurons.

  1994cited by this paper
• Highly selective effects of nerve growth factor, brain‐derived neurotrophic factor, and neurotrophin‐3 on intact and injured basal forebrain magnocellular neurons

  1994cited by this paper
• An Updated Role for Nerve Growth Factor in Neurobehavioural Regulation of Adult Vertebrates

  1993cited by this paper

• A novel finding on sex-dependent diverse behavioral responses to the anticipation of a threat in a rat model of fear conditioning with the involvement of brain-derived neurotrophic factor (BDNF) in the prefrontal cortex.

  2026cites this paper
• Low‐Intensity Pulsed Ultrasound Alleviation of LPS‐Induced Depression‐Like Behavior via Microglial P2X4R Inhibition and BDNF/TrkB Pathway Activation

  2026cites this paper
• Neonatal Handling Positively Modulates Anxiety, Sensorimotor Gating, Working Memory, and Cortico-Hippocampal Neuroplastic Adaptations in Two Genetically Selected Rat Strains Differing in Emotional and Cognitive Traits

  2025cites this paper
• Is it possible to prevent excessive synaptic pruning in schizophrenia? Possibilities and limitations

  2025cites this paper
• Hippocampal GPR17 down regulation ameliorates CMS-induced depression-like behaviors in mice.

  2025cites this paper
• Enhancing schizophrenia treatment efficacy: The combined impact of Yueju pill and olanzapine through quercetin target modulation

  2025cites this paper
• Selective recognition memory impairment in mitochondrial hydroxylase Clk1 mutant mice, rescued by antipsychotics

  2025cites this paper
• Impact of mild prenatal LPS-induced inflammation and postnatal stress on synaptic plasticity and neuroimmune responses in the prefrontal cortex of adult male mice.

  2025cites this paper
• Third-Generation Antipsychotics: The Quest for the Key to Neurotrophism

  2025cites this paper
• Magnesium and Zinc in Schizophrenia

  2025cites this paper
• Exploring the complex mechanisms of post-intracerebral hemorrhage depression: towards personalized treatment approaches

  2025cites this paper
• The Balance in the Head: How Developmental Factors Explain Relationships Between Brain Asymmetries and Mental Diseases

  2025cites this paper
• Unique and overlapping mechanisms of valbenazine, deutetrabenazine, and vitamin E for tardive dyskinesia

  2025cites this paper
• Impact of Relapse in BDNF Receptors Expression in Patients With a First Episode of Schizophrenia.

  2025cites this paper
• Curcumin ZnO and MgO Nanoparticles Confer Protective Effects Against Ketamine-Induced Bipolar Disorder in Mice: Role of Brain-Derived Neurotrophic Factor

  2025cites this paper
• Neonatal handling enhances behavioural and attentional domains, and frontocortical synaptic maturation in rat models of schizophrenia-like behaviour and anxiety-related responses.

  2025cites this paper
• Astrocyte‐Targeted connexin43 Hemichannel Inhibition Prevents Radiation‐Induced Energy Transporter Decrease in Neurons and Astrocytic proBDNF Transport to Synapses

  2025cites this paper
• Relationship Between Brain-Derived Neurotrophic Factor and Cognitive Function in Methamphetamine-Dependent Patients

  2025cites this paper
• Activation of BDNF–TrkB Signaling in Specific Structures of the Sheep Brain by Kynurenic Acid

  2024cites this paper
• Do Long‐Acting Injectable Antipsychotics Influence Serum Levels of Brain‐Derived Neurotrophic Factor in People With Schizophrenia and Schizoaffective Disorder?

  2024cites this paper
• Stress und Depression – eine neurobiologische Perspektive

  2024cites this paper
• Neurotrophins and Their Receptors: BDNF’s Role in GABAergic Neurodevelopment and Disease

  2024cites this paper
• Gut Microbiota and Autism Spectrum Disorder: A Neuroinflammatory Mediated Mechanism of Pathogenesis?

  2024cites this paper
• Evidence for the Contribution of the miR-206/BDNF Pathway in the Pathophysiology of Depression

  2024cites this paper
• Shared genetic architecture of cortical thickness alterations in major depressive disorder and schizophrenia.

  2024cites this paper
• The potential role of miRNAs in the pathogenesis of schizophrenia - A focus on signaling pathways interplay.

  2024cites this paper
• Sex difference alters the behavioral and cognitive performance in a rat model of schizophrenia induced by sub-chronic ketamine.

  2024cites this paper
• Overlapping hearing and communication profiles for the deletion and the RAI1 variant form of Smith-Magenis Syndrome (SMS).

  2024cites this paper
• Uncovering the genetic underpinnings for different psychiatric disorder combinations

  2024cites this paper
• The BDNF Val66Met polymorphism and health‐related quality of life in youth with obesity

  2024cites this paper
• Particulate matter induces depression-like behavior through systemic inflammation and brain-derived neurotrophic factors.

  2024cites this paper
• Exploring peripheral biomarkers in psychostimulant use: a systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors.

  2024cites this paper
• Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data.

  2024cites this paper
• Probiotic, prebiotic, synbiotic and fermented food supplementation in psychiatric disorders: A systematic review of clinical trials.

  2024cites this paper
• Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorder

  2024cites this paper
• BDNF blood levels as a potential biomarker Predictor of treatment response and remission in bipolar depression

  2024cites this paper
• Brain-derived neurotrophic factor (BDNF) in schizophrenia research: a quantitative review and future directions

  2023influential citation
• A Microbial-Based Approach to Mental Health: The Potential of Probiotics in the Treatment of Depression

  2023cites this paper
• Emerging epigenetic dynamics in gut-microglia brain axis: experimental and clinical implications for accelerated brain aging in schizophrenia

  2023cites this paper
• Correlations between omega-3 fatty acids and inflammatory/glial abnormalities: the involvement of the membrane and neurotransmitter dysfunction in schizophrenia

  2023cites this paper
• The Role of Brain-Derived Neurotrophic Factor (BDNF) in Depression and Cardiovascular Disease: A Systematic Review

  2023cites this paper
• Neuroprotective factors in schizophrenia: BDNF, NGF, NT3, GDNF and their connection to the pathogenesis of schizophrenia. A narrative review

  2023cites this paper
• Neurotoxicity, antipsychotic and antidepressant screening of the fruit of Rosa moschata in mice.

  2023cites this paper
• Decreased serum levels of glial markers and their relation with clinical parameters in patients with schizophrenia

  2023cites this paper
• A consideration of the increased risk of schizophrenia due to prenatal maternal stress, and the possible role of microglia.

  2023cites this paper
• Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with mental disorders: A systematic review and meta-analysis.

  2023cites this paper
• The role of BDNF in bipolar disorder and related treatment

  2023cites this paper
• The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration

  2023cites this paper
• The Role of Dopamine D3 Receptors, Dysbindin, and Their Functional Interaction in the Expression of Key Genes for Neuroplasticity and Neuroinflammation in the Mouse Brain

  2023cites this paper
• Role of Tyrosine Nitrosylation in Stress-Induced Major Depressive Disorder: Mechanisms and Implications

  2023cites this paper
• Effects of brain-derived neurotrophic factor (BDNF) on the Schizophrenia model of animals.

  2022cites this paper
• Psychiatric Manifestations of COVID-19: A Literature Review.

  2022cites this paper
• Transcranial Ultrasound Stimulation Reverses Behavior Changes and the Expression of Calcium-Binding Protein in a Rodent Model of Schizophrenia

  2022cites this paper
• Dietary flavonoids-rich Citrus reticulata peel extract interacts with CREB signaling to suppress seizures and linked neurobehavioral impairments in a kindling mouse model

  2022cites this paper
• Female Carriers of the Met Allele of the BDNF Val66Met Polymorphism Develop Weaker Fear Memories in a Fear-Potentiated Startle Paradigm

  2022cites this paper
• N-Acetylcysteine and Aripiprazole Improve Social Behavior and Cognition and Modulate Brain BDNF Levels in a Rat Model of Schizophrenia

  2022cites this paper
• Flaxseed Oil and Treadmill Running Improve Behavioral Outcomes in Rats Exposed to Lead

  2022cites this paper
• Sex Differences in Psychosis: Focus on Animal Models.

  2022cites this paper
• Can Neuropeptide S Be an Indicator for Assessing Anxiety in Psychiatric Disorders?

  2022cites this paper
• Are the measurement structures of the Traditional Chinese Dispositional Flow Scale-2 equivalent between schizophrenic patients and healthy subjects?

  2022cites this paper
• Fibroblast Growth Factor 9 as a Potential Biomarker for Schizophrenia

  2022cites this paper
• Physical Exercise in the Context of Air Pollution: An Emerging Research Topic

  2022cites this paper
• New Paradigms of Old Psychedelics in Schizophrenia

  2022cites this paper
• The evolution of BDNF is defined by strict purifying selection and prodomain spatial coevolution, but what does it mean for human brain disease?

  2022cites this paper
• Brain Derived Neurotrophic Factor and Cognitive Dysfunction in the Schizophrenia-Bipolar Spectrum: A Systematic Review and Meta-Analysis

  2022cites this paper
• The Role of the Second Extracellular Loop of Norepinephrine Transporter, Neurotrophin-3 and Tropomyosin Receptor Kinase C in T Cells: A Peripheral Biomarker in the Etiology of Schizophrenia

  2021cites this paper
• Trophic Factors as Potential Therapies for Treatment of Major Mental Disorders.

  2021cites this paper
• Decreased Brain pH and Pathophysiology in Schizophrenia

  2021cites this paper
• University of Groningen Physical exercise improves quality of life, depressive symptoms, and cognition across chronic brain disorders Dauwan,

  2021cites this paper
• The relationship between brain-derived neurotrophic factor and metabolic syndrome in patients with chronic schizophrenia: A systematic review.

  2021cites this paper
• Injection of Anti-proBDNF Attenuates Hippocampal-Dependent Learning and Memory Dysfunction in Mice With Sepsis-Associated Encephalopathy

  2021cites this paper
• Escitalopram Targets Oxidative Stress, Caspase-3, BDNF and MeCP2 in the Hippocampus and Frontal Cortex of a Rat Model of Depression Induced by Chronic Unpredictable Mild Stress

  2021cites this paper
• Biomarkers for Deep Brain Stimulation in Animal Models of Depression.

  2021cites this paper
• Impact of Repetitive Transcranial Magnetic Stimulation (rTMS) on Theory of Mind and Executive Function in Major Depressive Disorder and Its Correlation with Brain-Derived Neurotrophic Factor (BDNF): A Randomized, Double-Blind, Sham-Controlled Trial

  2021cites this paper
• Curcumin evokes antidepressant-like effects in mice by regulating miR-124/brain derived neurotrophic factor

  2021cites this paper
• Association of growth hormone deficiency (GHD) with anxiety and depression: experimental data and evidence from GHD children and adolescents

  2021cites this paper
• Neurobehavioral and neurodevelopmental profiles of a heuristic genetic model of differential schizophrenia- and addiction-relevant features: the RHA vs. RLA rats.

  2021cites this paper
• M2-AChR Mediates Rapid Antidepressant Effects of Scopolamine Through Activating the mTORC1-BDNF Signaling Pathway in the Medial Prefrontal Cortex

  2021cites this paper
• Contributions of animal models of cognitive disorders to neuropsychopharmacology.

  2021cites this paper
• Hippocampal neural cell loss in high-fat diet-induced obese rats-exploring the protein networks, ultrastructure, biochemical and bioinformatical markers.

  2021cites this paper
• TrkB agonist 7,8-dihydroxyflavone reverses an induced prepulse inhibition deficit selectively in maternal immune activation offspring: implications for schizophrenia

  2021cites this paper
• Gut microbiota in mental health and depression: role of pre/pro/synbiotics in their modulation.

  2021cites this paper
• Allosteric Modulation of the Sigma-1 Receptor Elicits Antipsychotic-like Effects.

  2021cites this paper
• M2-AChR Mediates Rapid Antidepressant-Like Effects of Scopolamine Through Activating the mTORC1-BDNF

  2021cites this paper
• p53 Knock Out Mice Enhances Anxiety- and Depression-Like Behaviors through an Increase of Glutamate, Calcium, and Cytokine-Mediated Cell Death Signals

  2021cites this paper
• Brain Derived Neurotrophic Factor Deficiency is Associated with Cognitive Impairment and Elevated Phospholipase A2 Activity in Plasma of Mice.

  2021cites this paper
• Main Biochemical Aspects of the Pathogenesis of Depression. Part II

  2021cites this paper
• There exists high ratio of, and significant overlap between, suspected dementia and suspected depression among elderly outpatients

  2021cites this paper
• Relating neurosteroid modulation of inhibitory neurotransmission to behaviour

  2021cites this paper
• Biomarkers of Post-COVID Depression

  2021cites this paper
• Elucidating the Possible Role of FoxO in Depression

  2021cites this paper
• Scutellarin alleviates depression-like behaviors induced by LPS in mice partially through inhibition of astrocyte-mediated neuroinflammation.

  2021cites this paper
• ω-3PUFAs Improve Cognitive Impairments Through Ser133 Phosphorylation of CREB Upregulating BDNF/TrkB Signal in Schizophrenia

  2020cites this paper
• ω-3PUFAs Improve Cognitive Impairments Through Ser133 Phosphorylation of CREB Upregulating BDNF/TrkB Signal in Schizophrenia

  2020cites this paper
• Antidepressant Drugs and Physical Activity: A Possible Synergism in the Treatment of Major Depression?

  2020cites this paper
• BDNF - A PROBABLE COMMON PATHOGENETIC FACTOR FOR SCHIZOPHRENIA AND DEPRESSIVE EPISODE

  2020cites this paper
• Depression as an Immunometabolic Disorder: Exploring Shared Pharmacotherapeutics with Cardiovascular Disease

  2020cites this paper
• Relationship of Brain-Derived Neurotrophic Factor with Interleukin-23, Testosterone and Disease Severity in Schizophrenia

  2020cites this paper
• Regulation of aging and cancer by enhanced environmental activation of a hypothalamic-sympathoneural-adipocyte axis

  2020cites this paper
• Fear stress in computer games caused brain waves, oxytocin and brain-derived neurotrophic factor changes among woman

  2020cites this paper